Sanket Koul
Sanket Koul
Delhi-NCR recorded the sharpest 19% jump in Q3 2025 housing prices, followed by Bengaluru and Hyderabad, as premium demand and limited supply continue to drive India's real estate boom
M3M India launches its 150-acre Gurgaon International City township project, marking its foray into integrated township space with plans to invest Rs 7,200 crore and generate Rs 12,000 crore topline
India has been overtaken by China as the most represented country in the QS Asia University Rankings 2026, even as it maintained leadership in research productivity and faculty strength.
Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions
Alembic Pharma's consolidated profit rose 21% to Rs 185 crore in Q2 FY26, led by strong performance in US generics, APIs, and international markets, with six new ANDA approvals
Smartworks has leased 815,000 sq ft from the Hiranandani Group's Eastbridge campus in Mumbai to build what it calls the world's largest managed workspace, set to open in late 2026
Alkem Foundation will contribute 20 to 25 per cent of its cumulative CSR obligations over seven years to this research centre
Real estate giant DLF plans new luxury project launches across Goa, Mumbai and Gurugram, while expecting rental income from its upcoming malls Midtown Plaza, Summit Plaza and DLF Promenade soon
Knight Frank-CII report says India's top developers are prioritising residential projects over office spaces due to higher margins and quicker returns, causing supply imbalances
Diagnostics chain declares ₹7 per share interim dividend, 1:1 bonus issue
According to the company's consolidated balance sheet, this drop could be attributed to rising overall tax expenses.
Health Canada's non-compliance notice may delay DRL's semaglutide generic launch by 8-12 months, say analysts; shares fall over 4 per cent on Thursday
At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals
Grant Thornton Bharat says India's pharma and healthcare sectors saw renewed investor confidence, driven by consolidation across pharma, biotech, and hospital segments
The Delhi NCR-based developer will use the funds to develop mid-income and ESG-aligned housing projects, repay Rs 470 crore of debt, and strengthen its balance sheet
International school boards IB, Cambridge, and WACE expand in India with teacher training, affordable programs, and growth beyond metros to Tier-2 and Tier-3 cities
The central drug regulator found one spurious cough syrup and 112 substandard formulations during its September 2025 checks, triggering detailed scrutiny
Premiums rise as AQI-assured homes attract eco-conscious buyers
Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML evaluation and algorithm change management
Delhi-NCR hospitals report a sharp spike in breathing-related cases as air quality turns 'severe' after Diwali; doctors expect numbers to rise in coming days